National Comprehensive Cancer Network

Recent papers from National Comprehensive Cancer Network

1. Phase II Single-Arm Study of Durvalumab and Bevacizumab Following Transarterial Radioembolisation in Unresectable Hepatocellular Carcinoma (EMERALD-Y90): Interim Safety Analysis with Contextualisation Using an External Comparator ArmCancers · 2026
2. Fostering Improvements in Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer CentersJournal of the National Comprehensive Cancer Network · 2026
3. Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer CentersJournal of the National Comprehensive Cancer Network · 2026
4. Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2026
5. Insights from initial scoring in the Health Equity Report Card (HERC) pilot in community oncology settings.Journal of Clinical Oncology · 2026
6. Bridging the Gap: Effective Strategies for Recruiting and Retaining Diverse Participants in Clinical TrialsJournal of Empirical Research on Human Research Ethics · 2026
7. NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026Journal of the National Comprehensive Cancer Network · 2026
8. Recommended Terms and Definitions From the 2025 NCCN Biomarkers Resource CommitteeJournal of the National Comprehensive Cancer Network · 2026
9. Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2026
10. NCCN Guidelines® Insights: Distress Management, Version 1.2026Journal of the National Comprehensive Cancer Network · 2026
11. NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026Journal of the National Comprehensive Cancer Network · 2026
12. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026Journal of the National Comprehensive Cancer Network · 2026
13. Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2026
14. Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2026
15. NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026Journal of the National Comprehensive Cancer Network · 2026
16. Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2025
17. NCCN Guidelines® Insights: Breast Cancer, Version 5.2025Journal of the National Comprehensive Cancer Network · 2025
18. Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2025
19. Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2025
20. NCCN Guidelines® Insights: Breast Cancer, Version 5.2025Journal of the National Comprehensive Cancer Network · 2025